Filter
1179
Text search:
drug
susceptibility
Featured
153
285
Language
Document type
629
211
198
60
36
18
14
10
2
1
Countries / Regions
61
43
33
31
27
27
25
24
21
19
18
17
17
15
14
14
13
11
10
9
9
9
8
7
7
6
6
6
6
6
5
5
5
5
4
4
4
4
4
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
376
136
59
26
23
18
16
Toolboxes
349
185
60
57
43
37
27
22
18
15
14
14
12
11
11
11
10
9
7
7
5
4
3
1
3rd edition
Training for staff working at DR-TB management centres.
Training modules
A practical tool to help health workers in the clinical and operational management of multidrug-resistant tuberculosis with special focus on the introduction, implementation and management of the nine-month treatment regimen.
2nd edition
Expert opinion of the European Tuberculosis Laboratory Initiative core group members for the WHO European Region.
These updates include shorter novel 6-month all-oral regimens for the treatment of multidrug- and rifampicin-resistant TB (MDR/RR-TB), with or without additional resistance to fluoroquinolones (pre-XDR-TB) as well as an alternative 9-month all-oral regimen for the treatment of MDR/RR-TB.
This Ra
...
In 2019, an estimated 10 million individuals fell ill with tuberculosis (TB) and 3 million of them were not reported to have beendiagnosed and notified. The gap is proportionately even wider for drug-resistant TB. Of the estimated 465 000 patients w
...
HIV & AIDS Treatment in Practice No.202
DR-TB drugs under the microscope: Sources and prices for drug-resistant tuberculosis medicines
recommended
Issue Brief 8th edition.
